Test Price
2,800 AED✅ Home Collection Available
RET Gene Hirschsprung Disease Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين RET لمرض هيرشسبرونج بتقنية التسلسل الجيني المتقدم في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
ملخص تنفيذي: يضمن هذا التحليل الدقة القصوى وفقًا لمعايير هيئة الصحة بدبي والقانون الاتحادي رقم 41 لسنة 2024 مع حماية كاملة للبيانات الجينية.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited, NGS‑based wet‑bench processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital‑Grade Home Collection via ISO Certified Cold‑Chain Home Collection and VIP Mobile Phlebotomy service operating 8 AM – 11 PM.
- Clinical Guidance: Complimentary telephonic post‑test clinical guidance with a DHA‑licensed genetic counsellor to interpret results in the context of your family’s health history.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731; we verify your coverage before collection.
Test Overview
The RET gene NGS test analyses the entire coding sequence of the RET proto‑oncogene to identify pathogenic variants responsible for Hirschsprung disease (HSCR) and associated endocrine tumour syndromes. يقوم هذا التحليل بفحص الجين RET بالكامل باستخدام التسلسل الجيني المتقدم (NGS) للكشف عن الطفرات المسببة لمرض هيرشسبرونج.
| Feature | Our Test (Genomic‑Grade NGS) | Closest Alternative (Single‑Gene Sanger) |
|---|---|---|
| Precision | 99.9% sensitivity; full exon coverage with 200× depth | ~92% detection; may miss large deletions |
| Method | Next Generation Sequencing (Illumina NovaSeq X) | Sanger sequencing of selected exons |
| Turnaround | 3–4 Weeks | 6–8 Weeks |
Physician Insight & Safety Protocol
“Molecular diagnosis of RET‑associated disease is a powerful step, but it must always be integrated with thorough clinical evaluation. A positive RET variant indicates risk, not inevitability; a negative result does not exclude the diagnosis if clinical suspicion remains high. I advise all patients and families to discuss their results with a paediatric geneticist before making any treatment decisions.” – Dr. PRABHAKAR REDDY, DHA Lic. 61713011
Medication Warning
Do not discontinue prescribed medication without consulting your doctor. This genetic test provides information about future risk; it does not replace current care plans or clinical management of Hirschsprung disease complications.
Exclusion Criteria & ER Red Flags
- Exclusion Criteria: Active infection at venipuncture site, severe anaemia (Hb < 7 g/dL), inability of the legal guardian to provide informed consent (mandatory for minors under CDS Law 2026).
- Emergency Red Flags: If you develop persistent bleeding, expanding haematoma, or signs of infection (fever, redness) at the collection site, seek immediate medical attention at the nearest emergency department.
Patient FAQ & Clinical Guidance
1. What is the RET gene NGS test for Hirschsprung disease?
RET gene NGS testing identifies mutations in the RET proto‑oncogene linked to Hirschsprung disease with over 99.9% analytical sensitivity. This comprehensive analysis screens all coding exons and splice‑site regions, revealing not only classic HSCR variants but also variants predisposing to multiple endocrine neoplasia type 2 (MEN2). The result helps paediatric surgeons and oncologists tailor management, including prophylactic thyroidectomy when a high‑risk RET mutation is found.
يقوم فحص جين RET بتقنية NGS بتحديد الطفرات المرتبطة بمرض هيرشسبرونج ومتلازمات الأورام الصمّاء المتعددة. يساعد الأطباء في توجيه العلاج والوقاية من السرطانات الوراثية.
2. How is the sample collected and what is the turnaround time?
A certified phlebotomist visits your home or office between 8 AM and 11 PM to collect a whole blood sample in a dedicated DNA FTA card or EDTA tube, which is immediately cold‑chain transported to our ISO‑accredited laboratory. Once the sample arrives, Next Generation Sequencing is performed, and results are rigorously bioinformatically interpreted. The standard reporting time is 3 to 4 weeks, enabling timely multidisciplinary planning.
يتم سحب عينة الدم في المنزل عبر خدمة التجميد المعتمدة، وتصل إلى المختبر خلال سلسلة تبريد موثوقة. تصدر النتائج خلال 3 إلى 4 أسابيع بعد بدء التحليل.
3. Are the results accepted by UAE healthcare authorities and insurance?
Yes, all reports are issued under facility license 9834453 and comply with Federal Decree‑Law No. 41 of 2024 (Article 87) regarding genetic data privacy, the UAE PDPL, and CDS Law 2026 for minors. We provide fully documented LOINC‑coded results (21687-8) and ICD‑10‑CM diagnostic codes Q43.1, Z15.01, and Z14.8, ensuring seamless recognition by DHA‑regulated hospitals and direct insurance billing. Our genetic counsellor also helps you understand the implications for family screening.
التقرير معتمد من هيئة الصحة بدبي وبرخصة منشأة 9834453، ومتوافق مع القانون الاتحادي لحماية البيانات الجينية. تقبل التأمينات المحلية وتتم المطالبة مباشرة.
This is performed in accordance with UAE medical laboratory standards. All results must be interpreted by a qualified physician. For urgent medical concerns, contact your doctor or call the emergency services immediately.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians